Jessica Stark
@jcstark.bsky.social
2.2K followers 620 following 22 posts
Understanding and engineering glycoimmunology | Asst Prof @ MIT BE, MIT ChemE, and Koch Institute for Integrative Cancer Research | jstarklab.com
Posts Media Videos Starter Packs
Reposted by Jessica Stark
nytimes.com
“It will take decades to recover from this, if we ever do.” America’s cancer research system, which has helped save millions of lives and is in one of its most productive moments, is under threat by the Trump administration.
Trump Is Shutting Down the War On Cancer
America’s cancer research system, which has helped save millions of lives, is under threat in one of its most productive moments.
nyti.ms
Reposted by Jessica Stark
Reposted by Jessica Stark
who.int
WHO @who.int · Aug 28
#ThrowbackThursday: In 1980 the 🌍🌎🌏 was declared #smallpox free, thanks to mass vaccination efforts.

Smallpox was an acute contagious disease caused by the variola virus. It was one of the most devastating diseases known to humanity. #VaccinesWork
World Health: The Magazine of the World Health Organization. May 1980. smallpox is dead!
jcstark.bsky.social
"The ideas and technologies that are being destroyed today, ... some of them irreversibly, those are the cures that would have been present 20 years from now."
"It’s people who will get cancer in 10, 20, or 30 years who will really pay the price for these cuts."

www.nytimes.com/2025/08/24/o...
Opinion | America First? Not When It Comes to Your Health.
www.nytimes.com
Reposted by Jessica Stark
carolynbertozzi.bskyverified.social
Spending a few days with intramural researcher at NIH has me thinking about the old Bell Labs, the storied research institute where major breakthroughs in physics, chemistry and mat sci (and associated @nobelprize.bsky.social awards) were made in the 70s-80s 1/n
jcstark.bsky.social
Fantastic news - congrats, Judith! 🍾
Reposted by Jessica Stark
labwaggoner.bsky.social
Federal science cuts aren’t just halting medical research or disrupting clinical trials. They are already costing us $8.1 billion and 35,000 jobs. The projected loss is $16 billion and 68,000 jobs every year. This reaches every corner of America.
scienceimpacts.org
SCIMaP - Impacts of Federal Cuts to Science and Medical Research
Developed by an interdisciplinary research team, this website shows how funding cuts reduce economic activity and employment nationwide
scienceimpacts.org
jcstark.bsky.social
Fantastic news - congrats! 🍾
Reposted by Jessica Stark
science.org
“As the Trump administration continues to drastically defund and dismantle basic science in America, the United States is presenting other countries with opportunities to take the lead …” writes H. Holden Thorp in a new #ScienceEditorial. scim.ag/43R82B5
"The United States will no longer have the same window into the technologies of the future ... " - H. Holden Thorpe, Editor-in-chief, Science journals
Reposted by Jessica Stark
erictopol.bsky.social
The gutting of US biomedical research with loss of ~2,500 grants affecting research for cancer, Alzheimer’s, infectious disease, global health and much more
www.nytimes.com/interactive/...
Reposted by Jessica Stark
erictopol.bsky.social
Where was this important 1st randomized trial performed?
China
Where are 8 of the 10 most productive research institutions in the world as of March 2025?
China
nature.com/nature-index...
What country is radically defunding research and will lose its competitiveness?
USA
jcstark.bsky.social
MIT ACCESS is an opportunity for undergraduates to explore cutting-edge research and graduate education in science and engineering. See for yourself what grad life is like at MIT!

Applications open June 1: access.mit.edu
@mitdeptofbe.bsky.social @mitcheme.bsky.social @mitchemistry.bsky.social
MIT ACCESS – Opening doors and promoting diversity in science and engineering
access.mit.edu
Reposted by Jessica Stark
jonlevybu.bsky.social
On a day when all research grants at Harvard were terminated, and in a context where Congress seems to broadly accept the notion that destroying science and health research in the US is fine, it’s worth noting that this is not what the public wants.
Reposted by Jessica Stark
mitkochinstitute.bsky.social
Go beyond the ABCs of ADCs! Join us for the 23rd Annual @kochinstitute Symposium on Antibody Drug Conjugates, June 27th! Our keynote speaker is Nobel-prize winner @carolynbertozzi.bskyverified.social of @stanford.edu & an array of industry and academic leaders. Register: mit-ki.org/4lfoxiz
Reposted by Jessica Stark
jcstark.bsky.social
Yes!! 🍾🥂 Congrats, Bryan!
jcstark.bsky.social
Great summary of last month's senate forum on what cuts to NIH funding mean for Americans: fewer treatments and fewer cures for diseases that collectively affect us all. Worth the ~12 min watch!
Image shows the title slide from video linked in quoted post that summarizes the March 26 senate forum titled “Cures in Crisis: What Gutting NIH Research Means for Americans with Cancer, Alzheimer’s, and Other Diseases"
jcstark.bsky.social
Yesterday we celebrated @mitdeptofbe.bsky.social PhD student Brian Cho, who received an honorable mention in this year's #NSFGRFP competition. Brian's work promises to shed new light on the adaptive immune response to glycans and glycoproteins. Congratulations! 🍾
jcstark.bsky.social
Congrats, Nick!! 🍾
Reposted by Jessica Stark
enirenberg.bsky.social
Peter Marks’s resignation letter. Everyone should read this.
Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research U.S. Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20903
March 28, 2025
Sara Brenner, MD, MPH
Acting Commissioner of Food and Drugs
U.S. Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20903
Dear Dr. Brenner:
It is with a heavy heart that I have decided to resign from FDA and retire from federal service as Director of the Center for Biologics Evaluation and Research effective April 5, 2025. I leave behind a staff of professionals who are undoubtedly the most devoted to protecting and promoting the public health of any group of people that I have encountered during my four decades working in the public and private sectors. I have always done my best to advocate for their well-being and I would ask that you do the same during this very difficult time during which their critical importance to the safety and security of our nation may be underappreciated.
Over the past years I have been involved in enhancing the safety of our nation's blood supply, in advancing the field of cell and gene therapy, and in responding to public health emergencies. In the last of these, during the COVID-19 pandemic I had the privilege of watching the vision that I conceived for Operation Warp Speed in March 2020 in collaboration with Dr. Robert Kadlec become a reality under the leadership of HHS Secretary Azar and President Trump due to the unwavering commitment of public servants at FDA and elsewhere across the government. At FDA, the tireless efforts of staff across the agency resulted in remarkably expediting the development of vaccines against the virus, meeting the standards for quality, safety, and effectiveness expected by the American public. The vaccines undoubtedly markedly reduced morbidity and mortality from COVID-19 in the United States and elsewhere. Many of these same individuals applied learnings from the pandemic during a flawless response helping… ongoing multistate measles outbreak that is particularly severe in Texas reminds us of what happens when confidence in well-established science underlying public health and well-being is undermined.
Measles, which killed more than 100,000 unvaccinated children last year in Africa and Asia owing to pneumonitis and encephalitis caused by the virus, had been eliminated from our shores. The two-dose measles, mumps, rubella vaccine regimen (MMR) using over the past decades has a remarkably favorable benefit-risk profile. The MMR vaccine is 97% or more effective in preventing measles following the two-dose series, and its safety has been remarkably well studied. Though rarely followed by a single fever-related seizure, or very rarely by allergic reactions or blood clotting disorders, the vaccine very simply does not cause autism, nor is it associated with encephalitis or death. It does, however, protect against a potential devasting consequence of prior measles infection, subacute sclerosing panencephalitis (SSPE), which is an untreatable, relentlessly progressive neurologic disorder leading to death in about 1 in 10,000 individuals infected with measles. Undermining confidence in well-established vaccines that have met the high standards for quality, safety, and effectiveness that have been in place for decades at FDA is irresponsible, detrimental to public health, and a clear danger to our nation's health, safety. and security.
In the years following the pandemic, at the Center for Biologics Evaluation and Research we have applied the same unwavering commitment to public health priorities to the development of cell and gene therapies to address both hereditary and acquired rare diseases. During my tenure as Center Director we have approved 22 gene therapies, including the first gene therapy ever to be approved in the United States. However, we know that we must do better to expedite the development of treatments for those individual suffering from any one of the thousan…
jcstark.bsky.social
Awesome work, congrats!!